Oct 30, 2026 · 7 min
Intel and Reddit stumble as Regeneron beats expectations
Intel Plummets, Reddit Plunges, Regeneron Climbs on ‘Exceptional’ 3Q Earnings Beat
The contrasting moves show how weak forward guidance and engagement concerns can outweigh optimism, while strong drug sales still reward execution.
- 1Intel’s weak outlook exposed how PC and memory-market weakness is pressuring demand.
- 2Reddit fell as user growth, projected revenue, and search traffic disappointed expectations.
- 3Regeneron rose after third-quarter revenue and adjusted profit beat estimates, helped by Dupixent sales.
Don't miss
Regeneron breaks from the day’s declines as strong drug sales, including Dupixent, help it beat third-quarter expectations.
The brief
Avalon Purnell joins the Stock Movers Report to examine three sharply different market reactions: Intel and Reddit fell, while Regeneron climbed after its results.
Intel’s decline reflects more than a disappointing forecast: the discussion connects its weaker outlook and downgrade to severe weakness across PC and memory markets.
Reddit’s shares sank as daily active users and projected fourth-quarter revenue missed expectations, with search-traffic concerns adding pressure to the growth story.
Regeneron supplied the counterpoint, rising after third-quarter revenue and adjusted profit beat estimates, driven partly by strong drug sales including Dupixent.
The episode’s central contrast is clear: fragile demand and slowing user growth punished Intel and Reddit, while strong commercial execution lifted Regeneron.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.